Kodiak Sciences Inc (KOD): IPOs News

KOD – Priced its IPO of 9M common shares at $10/share.


Key Facts Surrounding This News Item


  • KOD had returned 0.00% year-to-date leading up to today’s news, versus a +10.75% return from the benchmark S&P 500 during the same period.

More Info About Kodiak Sciences Inc (KOD)


Kodiak Sciences is a clinical stage biopharma specializing in therapeutics to treat chronic retinal diseases. The company was founded in 2005 and is based in New York City, New York. View our full KOD ticker page with ratings, news, and more.

Try StockNews.com Premium Today!


Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

KOD at a Glance

KOD Current POWR Rating™
Overall POWR Rating™
KOD Current Price $9.89 0.80%
More KOD Ratings, Data, and News

KOD Price Reaction

The day of this event (Oct. 4, 2018)
KOD Closing Price$10.16 N/A%
KOD Volume2,409,400
N/A% from avg
Leading up to this event
KOD 1-mo returnN/A%
After this event
KOD 1-day returnN/A%
KOD 3-day returnN/A%
KOD 5-day returnN/A%

KOD Price Chart



More Kodiak Sciences Inc (KOD) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All KOD News
Page generated in 0.7594 seconds.